U S Physical Therapy Inc 8-K, filed Sep 21, 2026
U S Physical Therapy Inc (USPH)
8-K
2026-09-21
For: 2026-09-15
View Original
Added on
September 21, 2026
About this 8-K
U S Physical Therapy Inc filed this 8-K on September 21, 2026, reporting on events of September 15, 2026.
Items reported
- Item 5.02: Director or officer change, or executive pay
- Item 9.01: Financial statements and exhibits
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 15, 2026
(Exact name of registrant as specified in its charter)
|
|
|
|
||
|
(State or other jurisdiction
of incorporation or organization)
|
(Commission
File Number)
|
(I.R.S. Employer
Identification No.)
|
|
|
|
|
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
Registrant's telephone number, including area code: (713 ) 297-7000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions ( see General Instruction A.2. below):
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12)
|
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
|
Emerging growth company
|
|
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
|
◻
|
ITEM 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers.
On September 15, 2026,
U.S. Physical Therapy Inc.’s (“Company”) Board of Directors (the “Board”) approved the appointment of Ms. Myra Davis to serve as a member of the Board, effective October 1, 2026.
Myra Davis, 61, currently
serves as the Executive Vice President and Chief Information Innovation Officer at Texas Children’s Hospital, a position she held since 2023. She has served in a variety of information services and information technology roles at Texas Children’s
Hospital since 2003, including Senior Vice President and Chief Information and Innovation Officer from 2019 to 2023 and Chief Information Officer from 2009 through 2019. In this role, Ms. Davis leads enterprise technology strategy, digital
transformation, innovation, and information services for one of the nation’s leading pediatric healthcare organizations. With more than two decades of CIO-level healthcare leadership, Ms. Davis is recognized for advancing secure, scalable
technology solutions, cultivating high-performing teams, and positioning technology as a catalyst for innovation, operational excellence, and improved care delivery. Ms. Davis also serves on the Board of Directors of Werfen, a global medical
diagnostics company, and on the Advisory Board of Healthcare Information Management Systems Society of America. Ms. Davis received a Bachelor of Science degree in Computer Information Processing from Loyola University, and a Master of Science
degree in Software Design and Development from the University of St. Thomas.
As of the date of this
Current Report on Form 8-K, Ms. Davis has not been appointed to any committee of the Board.
Upon joining the Board on October 1, 2026, Ms. Davis will be entitled to receive an annual cash retainer and annual equity grant, both of which will be based on the terms, and in the amounts, as determined in accordance with the processes described in the “Director Compensation” section of the Company’s definitive proxy statement filed with the Securities and Exchange Commission (the “SEC”) on April 16, 2026.
Upon joining the Board on October 1, 2026, Ms. Davis will be entitled to receive an annual cash retainer and annual equity grant, both of which will be based on the terms, and in the amounts, as determined in accordance with the processes described in the “Director Compensation” section of the Company’s definitive proxy statement filed with the Securities and Exchange Commission (the “SEC”) on April 16, 2026.
There are no arrangements or understandings between
Ms. Davis and any other person pursuant to which she was selected to serve as a director. There are no related-party transactions between Ms. Davis and the Company that are reportable under Item 404(a) of Regulation S-K.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
|
Exhibit
|
Description of Exhibits
|
|
| 99.1 |
Press release dated September 21, 2026.
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
U.S. PHYSICAL THERAPY, INC.
|
|||||||
|
Dated: September 21, 2026
|
By:
|
/s/ NCHAHCA ETTA
|
|||||
|
Nchacha Etta
|
|||||||
|
Chief Financial Officer
|
|||||||
|
(duly authorized officer and principal financial and accounting officer)
|
|||||||
CONTACT:
U.S. Physical Therapy, Inc.
Nchacha Etta, Chief Financial Officer
email: netta@usph.com
Chris Reading, Chief Executive Officer
(713) 297-7000
Three Part Advisors
Joe Noyons
(817) 778-8424
Exhibit 99.1
U.S. Physical Therapy Announces the Appointment
of New Board Member Myra Davis
Houston, TX, September 21, 2026 – U.S. Physical
Therapy, Inc. (“USPH” or the “Company”) (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today announced that its Board of Directors (the “Board”) approved the
appointment of Ms. Myra Davis to serve as a member of the Board, effective October 1, 2026.
Myra Davis currently serves as the Executive Vice President and Chief Information Innovation Officer at Texas Children’s Hospital, a position she
held since 2023. She has served in a variety of information services and information technology roles at Texas Children’s Hospital since 2003, including Senior Vice President and Chief Information and Innovation Officer from 2019 to 2023 and Chief
Information Officer from 2009 through 2019. In this role, Ms. Davis leads enterprise technology strategy, digital transformation, innovation, and information services for one of the nation’s leading pediatric healthcare organizations. With more than
two decades of CIO-level healthcare leadership, Ms. Davis is recognized for advancing secure, scalable technology solutions, cultivating high-performing teams, and positioning technology as a catalyst for innovation, operational excellence, and
improved care delivery. Ms. Davis also serves on the Board of Directors of Werfen, a global medical diagnostics company, and on the Advisory Board of Healthcare Information Management Systems Society of America. Ms. Davis received a Bachelor of
Science degree in Computer Information Processing from Loyola University, and a Master of Science degree in Software Design and Development from the University of St. Thomas.
Chris Reading, Chairman of the Board, CEO and Director, stated, “Myra brings a wealth of technology experience, strategic insight and leadership
experience to our Board. We are confident her background in technology and innovation will provide valuable perspective as we continue to position our Company for long-term success. Our entire Board and executive team look forward to working with
Myra and benefiting from her experience.”
About U.S. Physical Therapy, Inc.
Founded in 1990, U.S. Physical Therapy, Inc. owns and/or manages 799 outpatient physical therapy clinics in 45 states. USPH clinics provide
preventative and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, treatment for neurologically related injuries and rehabilitation of injured workers. USPH also has an industrial injury prevention
business which provides onsite services for clients’ employees including injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments.
More information about U.S. Physical Therapy, Inc. is available at www.usph.com. The information included on that website is not incorporated into
this press release.